144 related articles for article (PubMed ID: 12143833)
1. Photodynamic therapy (PDT) for oesophageal dysplasia and early carcinoma with mTHPC (m-Tetrahidroxyphenyl chlorin): a preliminary study.
Javaid B
Lasers Med Sci; 2002; 17(2):135. PubMed ID: 12143833
[No Abstract] [Full Text] [Related]
2. Photodynamic therapy (PDT) for oesophageal dysplasia and early carcinoma with mTHPC (m-tetrahydroxyphenyl chlorin): a preliminary study.
Javaid B; Watt P; Krasner N
Lasers Med Sci; 2002; 17(1):51-6. PubMed ID: 11845368
[TBL] [Abstract][Full Text] [Related]
3. Optimizing light dosimetry in photodynamic therapy of early stage carcinomas of the esophagus using fluorescence spectroscopy.
Braichotte DR; Savary JF; Monnier P; van den Bergh HE
Lasers Surg Med; 1996; 19(3):340-6. PubMed ID: 8923430
[TBL] [Abstract][Full Text] [Related]
4. Effective treatment of liver metastases with photodynamic therapy, using the second-generation photosensitizer meta-tetra(hydroxyphenyl)chlorin (mTHPC), in a rat model.
Rovers JP; Saarnak AE; Molina A; Schuitmaker JJ; Sterenborg HJ; Terpstra OT
Br J Cancer; 1999 Oct; 81(4):600-8. PubMed ID: 10574244
[TBL] [Abstract][Full Text] [Related]
5. Schedule-dependent interaction between Doxorubicin and mTHPC-mediated photodynamic therapy in murine hepatoma in vitro and in vivo.
Kirveliene V; Grazeliene G; Dabkeviciene D; Micke I; Kirvelis D; Juodka B; Didziapetriene J
Cancer Chemother Pharmacol; 2006 Jan; 57(1):65-72. PubMed ID: 16001168
[TBL] [Abstract][Full Text] [Related]
6. Meta-tetra(hydroxyphenyl)chlorin photodynamic therapy in early-stage squamous cell carcinoma of the head and neck.
Copper MP; Tan IB; Oppelaar H; Ruevekamp MC; Stewart FA
Arch Otolaryngol Head Neck Surg; 2003 Jul; 129(7):709-11. PubMed ID: 12874068
[TBL] [Abstract][Full Text] [Related]
7. Photodynamic therapy for cancer of the upper aerodigestive tract using tetra(m-hydroxyphenyl)chlorin.
Grosjean P; Savary JF; Mizeret J; Wagnieres G; Woodtli A; Theumann JF; Fontolliet C; Van den Bergh H; Monnier P
J Clin Laser Med Surg; 1996 Oct; 14(5):281-7. PubMed ID: 9612194
[TBL] [Abstract][Full Text] [Related]
8. Effects of chlorin-mediated photodynamic therapy combined with fluoropyrimidines in vitro and in a patient.
Zimmermann A; Walt H; Haller U; Baas P; Klein SD
Cancer Chemother Pharmacol; 2003 Feb; 51(2):147-54. PubMed ID: 12647016
[TBL] [Abstract][Full Text] [Related]
9. Photodynamic therapy of early squamous cell cancers of the esophagus.
Radu A; Wagnières G; van den Bergh H; Monnier P
Gastrointest Endosc Clin N Am; 2000 Jul; 10(3):439-60. PubMed ID: 10900053
[TBL] [Abstract][Full Text] [Related]
10. Photodynamic therapy using meso tetra hydroxy phenyl chlorin (mTHPC) in early prostate cancer.
Moore CM; Nathan TR; Lees WR; Mosse CA; Freeman A; Emberton M; Bown SG
Lasers Surg Med; 2006 Jun; 38(5):356-63. PubMed ID: 16392142
[TBL] [Abstract][Full Text] [Related]
11. Effect of the TAT-RasGAP(317-326) peptide on apoptosis of human malignant mesothelioma cells and fibroblasts exposed to meso-tetra-hydroxyphenyl-chlorin and light.
Pittet O; Petermann D; Michod D; Krueger T; Cheng C; Ris HB; Widmann C
J Photochem Photobiol B; 2007 Jul; 88(1):29-35. PubMed ID: 17560792
[TBL] [Abstract][Full Text] [Related]
12. Photodynamic therapy as novel nephron sparing treatment option for small renal masses.
Kroeze SG; Grimbergen MC; Rehmann H; Bosch JL; Jans JJ
J Urol; 2012 Jan; 187(1):289-95. PubMed ID: 22099991
[TBL] [Abstract][Full Text] [Related]
13. Photodynamic therapy using meta-tetrahydroxyphenylchlorin (Foscan) for the treatment of vulval intraepithelial neoplasia.
Campbell SM; Gould DJ; Salter L; Clifford T; Curnow A
Br J Dermatol; 2004 Nov; 151(5):1076-80. PubMed ID: 15541088
[TBL] [Abstract][Full Text] [Related]
14. Experimental photodynamic therapy for malignant pleural mesothelioma with pegylated mTHPC.
Krueger T; Altermatt HJ; Mettler D; Scholl B; Magnusson L; Ris HB
Lasers Surg Med; 2003; 32(1):61-8. PubMed ID: 12516073
[TBL] [Abstract][Full Text] [Related]
15. Temoporfin (Foscan®, 5,10,15,20-tetra(m-hydroxyphenyl)chlorin)--a second-generation photosensitizer.
Senge MO; Brandt JC
Photochem Photobiol; 2011; 87(6):1240-96. PubMed ID: 21848905
[TBL] [Abstract][Full Text] [Related]
16. Optimization of treatment parameters for Foscan-PDT of basal cell carcinomas.
Betz CS; Rauschning W; Stranadko EP; Riabov MV; Albrecht V; Nifantiev NE; Hopper C
Lasers Surg Med; 2008 Jul; 40(5):300-11. PubMed ID: 18563776
[TBL] [Abstract][Full Text] [Related]
17. Outcome of mTHPC mediated photodynamic therapy is primarily determined by the vascular response.
Triesscheijn M; Ruevekamp M; Aalders M; Baas P; Stewart FA
Photochem Photobiol; 2005; 81(5):1161-7. PubMed ID: 15934792
[TBL] [Abstract][Full Text] [Related]
18. Stability of the fluorescence measurement of Foscan in the normal human oral cavity as an indicator of its content in early cancers of the esophagus and the bronchi.
Zellweger M; Grosjean P; Monnier P; van den Bergh H; Wagnières G
Photochem Photobiol; 1999 May; 69(5):605-10. PubMed ID: 10333768
[TBL] [Abstract][Full Text] [Related]
19. mTHPC-mediated photodynamic therapy is effective in the metastatic human 143B osteosarcoma cells.
Reidy K; Campanile C; Muff R; Born W; Fuchs B
Photochem Photobiol; 2012; 88(3):721-7. PubMed ID: 22268498
[TBL] [Abstract][Full Text] [Related]
20. Pulse oximeter as a cause of skin burn during photodynamic therapy.
Radu A; Zellweger M; Grosjean P; Monnier P
Endoscopy; 1999 Nov; 31(9):831-3. PubMed ID: 10604626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
